Stockpolly
Search
Delisting risk
COCH · NASDAQ · Medical - Devices

Envoy Medical (COCH)

Develops fully implanted hearing devices that use the natural ear as a sound sensor.

$0.6948
At close−0.01 (−1.36%)
Watchlist

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
375554556665
Research & development232332323543
142222223222
Selling & marketing010001000000
General & administrative132221222222
Operating income−3−7−5−5−5−5−5−5−6−6−6−6
52−11−100−1−1020
Interest expense000000010000
Other non-operating income−5−21−110−1000−20
Income before tax2−5−6−4−6−5−5−6−6−7−4−6
Net income from continuing operations2−5−6−4−6−5−5−6−6−7−4−6
Net income2−5−6−4−6−5−5−6−6−7−4−6
EPS, basic$0.07−$0.25−$0.41−$0.27−$0.37−$0.36−$0.29−$0.32−$0.35−$0.17−$0.08−$0.07
EPS, diluted$0.07−$0.25−$0.41−$0.27−$0.37−$0.36−$0.29−$0.32−$0.35−$0.17−$0.08−$0.07
Weighted average shares, basic2020192020212120224669104
Weighted average shares, diluted2020192020212120224669104
EBITDA2−5−6−4−6−4−4−5−6−7−4−5
Depreciation & amortization000000000000
EBIT2−5−6−4−6−4−5−5−6−7−4−5